Healthcare Solutions
Deep brain stimulation program marks milestones
Mar. 24, 2016—Vanderbilt Clinical Neurosciences is marking two milestones — the 20th anniversary of its deep brain stimulation (DBS) program and its 1,000th DBS procedure.
New treatment for Crohn’s disease
Mar. 22, 2016—A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease.
Monroe Carell Jr. Children’s Hospital at Vanderbilt and Ryan Seacrest Foundation Open Seacrest Studios, a New Multimedia Broadcast Studio
Mar. 18, 2016—Taylor Swift Surprises Patients for the First Broadcast with Seacrest Monroe Carell Jr. Children’s Hospital at Vanderbilt, in partnership with the Ryan Seacrest Foundation (RSF), today celebrated the opening of a new state-of-the-art, multimedia broadcast studio, named Seacrest Studios, inside Children’s Hospital. The launch of Seacrest Studios at Children’s Hospital marks the 10th broadcast media...
Study suggests cancer’s ‘clock’ can be rewound
Mar. 17, 2016—Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented.
Life-changing impact of cornea transplantation celebrated
Mar. 17, 2016—Since 1961, the Eye Bank Association of America has provided donors for more than 1.5 million corneal transplants nationwide. And for nearly 25 years, the group has celebrated corneal transplant recipients, promoted awareness of the need to donate and recognized donors and families during National Eye Donor Month in March.
Study explores carb-loading’s effect on heart
Mar. 17, 2016—Drinking a high carbohydrate shake can have an acute and detrimental effect on heart function, a study published in the Journal of the American College of Cardiology (JACC) has found.
FDA approves Vanderbilt-designed Indego exoskeleton for clinical and personal use
Mar. 10, 2016—The U.S. Food and Drug Administration has given clearance to market and sell the powered lower-limb exoskeleton created by a team of Vanderbilt engineers and commercialized by the Parker Hannifin Corporation for both clinical and personal use in the United States.
Vanderbilt researchers identify potential antibody treatment for H7 avian flu
Mar. 7, 2016—Researchers at Vanderbilt University Medical Center have isolated human antibodies against a type of bird flu that has killed more than 200 people in China since 2012 and which may pose a worldwide pandemic threat.
First VICC cancer patient treated with new immunotherapy
Mar. 3, 2016—For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system.
Study seeks to ease pediatric HIV infection rates in Africa
Mar. 3, 2016—Mother-to-child transmission of the human immunodeficiency virus (HIV), which causes AIDS, is still a major problem in resource-limited, rural areas of the world where health care providers are scarce.
Compassion key to VUMC’s strategic mission: Balser
Feb. 18, 2016— “Service through compassion” was the theme of the Winter 2016 Clinical Enterprise Leadership Assembly at Vanderbilt University Medical Center (VUMC).
Study explores less invasive way to monitor colorectal cancer
Feb. 18, 2016—Investigators at Vanderbilt University Medical Center have published research regarding an important feature of colorectal cancer (CRC) that could eventually lead to the development of non-invasive means of monitoring cancer progression. After lung cancer, CRC is the second-most lethal cancer in the United States.
